These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 39396060)

  • 21. Limited Added Diagnostic Value of Whole Genome Sequencing in Genetic Testing of Inherited Retinal Diseases in a Swiss Patient Cohort.
    Maggi J; Koller S; Feil S; Bachmann-Gagescu R; Gerth-Kahlert C; Berger W
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The current benefit of genome sequencing compared to exome sequencing in patients with developmental or epileptic encephalopathies.
    Grether A; Ivanovski I; Russo M; Begemann A; Steindl K; Abela L; Papik M; Zweier M; Oneda B; Joset P; Rauch A
    Mol Genet Genomic Med; 2023 May; 11(5):e2148. PubMed ID: 36785910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole genome sequencing analysis for cancer genomics and precision medicine.
    Nakagawa H; Fujita M
    Cancer Sci; 2018 Mar; 109(3):513-522. PubMed ID: 29345757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome.
    Rusch M; Nakitandwe J; Shurtleff S; Newman S; Zhang Z; Edmonson MN; Parker M; Jiao Y; Ma X; Liu Y; Gu J; Walsh MF; Becksfort J; Thrasher A; Li Y; McMurry J; Hedlund E; Patel A; Easton J; Yergeau D; Vadodaria B; Tatevossian RG; Raimondi S; Hedges D; Chen X; Hagiwara K; McGee R; Robinson GW; Klco JM; Gruber TA; Ellison DW; Downing JR; Zhang J
    Nat Commun; 2018 Sep; 9(1):3962. PubMed ID: 30262806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical application of whole-genome sequencing of solid tumors for precision oncology.
    Kim R; Kim S; Oh BB; Yu WS; Kim CW; Hur H; Son SY; Yang MJ; Cho DS; Ha T; Heo S; Jang JY; Yun JS; Kwack KS; Kim JK; Huh J; Lim SG; Han SU; Lee HW; Park JE; Kim CH; Roh J; Koh YW; Lee D; Kim JH; Lee GH; Noh CK; Jung YJ; Park JW; Sheen S; Ahn MS; Choi YW; Kim TH; Kang SY; Choi JH; Baek SY; Lee KM; Il Kim S; Noh SH; Kim SH; Hwang H; Joo E; Lee S; Shin JY; Yun JY; Park J; Yi K; Kwon Y; Lee WC; Park H; Lim J; Yi B; Koo J; Koh JY; Lee S; Lee Y; Lee BR; Connolly-Strong E; Ju YS; Kwon M
    Exp Mol Med; 2024 Aug; 56(8):1856-1868. PubMed ID: 39138315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targets.
    Asada K; Kaneko S; Takasawa K; Shiraishi K; Shinkai N; Shimada Y; Takahashi S; Machino H; Kobayashi K; Bolatkan A; Komatsu M; Yamada M; Miyake M; Watanabe H; Tateishi A; Mizuno T; Okubo Y; Mukai M; Yoshida T; Yoshida Y; Horinouchi H; Watanabe SI; Ohe Y; Yatabe Y; Kohno T; Hamamoto R
    Mol Cancer; 2024 Sep; 23(1):182. PubMed ID: 39218851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
    Mackley MP; Fletcher B; Parker M; Watkins H; Ormondroyd E
    Genet Med; 2017 Mar; 19(3):283-293. PubMed ID: 27584911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Positively and Negatively Selected Driver Gene Mutations Associated With Colorectal Cancer With Microsatellite Instability.
    Jonchere V; Marisa L; Greene M; Virouleau A; Buhard O; Bertrand R; Svrcek M; Cervera P; Goloudina A; Guillerm E; Coulet F; Landman S; Ratovomanana T; Job S; Ayadi M; Elarouci N; Armenoult L; Merabtene F; Dumont S; Parc Y; Lefèvre JH; André T; Fléjou JF; Guilloux A; Collura A; de Reyniès A; Duval A
    Cell Mol Gastroenterol Hepatol; 2018; 6(3):277-300. PubMed ID: 30116770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robust identification of deletions in exome and genome sequence data based on clustering of Mendelian errors.
    Manheimer KB; Patel N; Richter F; Gorham J; Tai AC; Homsy J; Boskovski MT; Parfenov M; Goldmuntz E; Chung WK; Brueckner M; Tristani-Firouzi M; Srivastava D; Seidman JG; Seidman CE; Gelb BD; Sharp AJ
    Hum Mutat; 2018 Jun; 39(6):870-881. PubMed ID: 29527824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Whole exome sequencing and whole genome sequencing in undiagnosed disease: of value for certain patient populations].
    Linthorst GE; Hollak CEM
    Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence.
    Nurchis MC; Riccardi MT; Radio FC; Chillemi G; Bertini ES; Tartaglia M; Cicchetti A; Dallapiccola B; Damiani G
    Health Policy; 2022 Apr; 126(4):337-345. PubMed ID: 35317923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling.
    Mørup SB; Nazaryan-Petersen L; Gabrielaite M; Reekie J; Marquart HV; Hartling HJ; Marvig RL; Katzenstein TL; Masmas TN; Lundgren J; Murray DD; Helleberg M; Borgwardt L
    Front Immunol; 2022; 13():906328. PubMed ID: 35874679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome and RNA sequencing were essential to reveal cryptic intronic variants associated to defective ATP6AP1 mRNA processing.
    Morales-Romero B; Muñoz-Pujol G; Artuch R; García-Cazorla A; O'Callaghan M; Sykut-Cegielska J; Campistol J; Moreno-Lozano PJ; Oud MM; Wevers RA; Lefeber DJ; Esteve-Codina A; Yepez VA; Gagneur J; Wortmann SB; Prokisch H; Ribes A; García-Villoria J; Tort F
    Mol Genet Metab; 2024 Jul; 142(3):108511. PubMed ID: 38878498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detecting Expansions of Tandem Repeats in Cohorts Sequenced with Short-Read Sequencing Data.
    Tankard RM; Bennett MF; Degorski P; Delatycki MB; Lockhart PJ; Bahlo M
    Am J Hum Genet; 2018 Dec; 103(6):858-873. PubMed ID: 30503517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline whole genome sequencing in adults with multiple primary tumors.
    Wang Y; Ding Q; Prokopec S; Farncombe KM; Bruce J; Casalino S; McCuaig J; Szybowska M; van Engelen K; Lerner-Ellis J; Pugh TJ; Kim RH
    Fam Cancer; 2023 Oct; 22(4):513-520. PubMed ID: 37481477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole genome and exome sequencing reference datasets from a multi-center and cross-platform benchmark study.
    Zhao Y; Fang LT; Shen TW; Choudhari S; Talsania K; Chen X; Shetty J; Kriga Y; Tran B; Zhu B; Chen Z; Chen W; Wang C; Jaeger E; Meerzaman D; Lu C; Idler K; Ren L; Zheng Y; Shi L; Petitjean V; Sultan M; Hung T; Peters E; Drabek J; Vojta P; Maestro R; Gasparotto D; Kõks S; Reimann E; Scherer A; Nordlund J; Liljedahl U; Foox J; Mason CE; Xiao C; Hong H; Xiao W
    Sci Data; 2021 Nov; 8(1):296. PubMed ID: 34753956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seeking the driver in tumours with apparent normal molecular profile on comparative genomic hybridization and targeted gene panel sequencing: what is the added value of whole exome sequencing?
    Postel-Vinay S; Boursin Y; Massard C; Hollebecque A; Ileana E; Chiron M; Jung J; Lee JS; Balogh Z; Adam J; Vielh P; Angevin E; Lacroix L; Soria JC
    Ann Oncol; 2016 Feb; 27(2):344-52. PubMed ID: 26598538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers.
    Khater F; Vairy S; Langlois S; Dumoucel S; Sontag T; St-Onge P; Bittencourt H; Dal Soglio D; Champagne J; Duval M; Leclerc JM; Laverdiere C; Tran TH; Patey N; Ellezam B; Perreault S; Piché N; Samson Y; Teira P; Jabado N; Michon B; Brossard J; Marzouki M; Cellot S; Sinnett D
    JAMA Netw Open; 2019 Apr; 2(4):e192906. PubMed ID: 31026031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALPHLARD: a Bayesian method for analyzing HLA genes from whole genome sequence data.
    Hayashi S; Yamaguchi R; Mizuno S; Komura M; Miyano S; Nakagawa H; Imoto S
    BMC Genomics; 2018 Nov; 19(1):790. PubMed ID: 30384854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Exome and Genome Sequencing Technologies for the Complete Capture of Protein-Coding Regions.
    Lelieveld SH; Spielmann M; Mundlos S; Veltman JA; Gilissen C
    Hum Mutat; 2015 Aug; 36(8):815-22. PubMed ID: 25973577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.